Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > BBIO BridgeBio Pharma > Detailed Quotes

BBIO BridgeBio Pharma

Watchlist
9.110
+0.260+2.94%
Close  01/27 16:00 ET
8.710
-0.400-4.39%
Post Mkt Price 01/27 17:58 ET
High
9.260
Open
8.750
Turnover
8.80M
Low
8.750
Pre Close
8.850
Volume
975.13K
Market Cap
1.36B
P/E(TTM)
Loss
52wk High
12.638
Shares
149.48M
P/E(Static)
Loss
52wk Low
4.980
Float Cap
718.98M
Bid/Ask %
0.00%
Historical High
73.500
Shs Float
78.92M
Volume Ratio
0.72
Historical Low
4.980
Dividend TTM
--
Div Yield TTM
--
P/B
-1.20
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.24%
Amplitude
5.76%
Avg Price
9.025
Lot Size
1
Float Cap
718.98M
Bid/Ask %
0.00%
Historical High
73.500
Shs Float
78.92M
Volume Ratio
0.72
Historical Low
4.980
Dividend TTM
--
P/B
-1.20
Dividend LFY
--
Turnover Ratio
1.24%
Amplitude
5.76%
Avg Price
9.025
Lot Size
1
Price Forecast

News

Comment

Company Overview More
BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Frank McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.
CEO: Mr. Neil Kumar, PhD
Market: NASDAQ
Listing Date: 06/27/2019
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist